XML 19 R8.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net income $ 17,961 $ 8,872
Adjustments to reconcile net income to cash flow from operating activities:    
Depreciation and amortization 53,721 53,536
Accretion of loan discounts and premiums, net (2,395) (2,755)
Amortization of deferred financing costs, net 697 939
Stock compensation expense 3,389 4,734
(Gain on sale) loss on impairment of real estate assets, net (10,530) (985)
Gain on extinguishment of debt (203) 0
Amortization related to derivative instruments 316 318
Casualty losses 1,184 151
Equity in loss from investments in unconsolidated real estate entities 829 776
Other loss 1 312
Changes in assets and liabilities:    
Other assets 970 835
Accounts payable and accrued expenses (20,779) (19,121)
Accrued interest payable (772) 266
Other liabilities (332) (967)
Cash flow provided by operating activities 44,057 46,911
Cash flows from investing activities:    
Investments in unconsolidated real estate entities (1,272) (13,438)
Disposition of real estate properties, net 292,670 35,557
Capital expenditures (24,561) (28,973)
Real estate development expenditures (14,095) (12,667)
Proceeds from insurance claims 2,661 0
Cash flow provided by (used in) investing activities 255,403 (19,521)
Cash flows from financing activities:    
Proceeds from unsecured credit facility and term loans 94,000 57,000
Unsecured credit facility, secured credit facility and term loan repayments (220,152) (55,513)
Mortgage principal repayments and payoffs (142,537) (1,813)
Costs associated with debt payoffs (663) 0
Payments for deferred financing costs (242) 0
Distributions on common stock (36,149) (31,625)
Distributions to noncontrolling interests (951) (853)
Repurchase of shares related to equity award tax withholding (1,598) (3,757)
Costs from issuance of common stock, net 0 (13)
Cash flow used in financing activities (308,292) (36,574)
Net change in cash and cash equivalents, and restricted cash (8,832) (9,184)
Cash and cash equivalents, and restricted cash, beginning of period 50,732 44,017
Cash and cash equivalents, and restricted cash, end of the period 41,900 34,833
Reconciliation of cash, cash equivalents, and restricted cash to the Condensed Consolidated Balance Sheets    
Cash and cash equivalents 21,275 12,448
Restricted cash 20,625 22,385
Total cash, cash equivalents, and restricted cash, end of period $ 41,900 $ 34,833